Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 36
Filtrar
1.
Rev. argent. dermatol ; 95(4): 30-35, dic. 2014. ilus
Artículo en Español | LILACS | ID: lil-734565

RESUMEN

Varios estudios epidemiológicos de la radiación ionizante y el cáncer de piel, han demostrado que la radiación causa cáncer de piel no melanoma, principalmente carcinoma basocelular. Poco se sabe sobre la dosis de radiación ionizante, que podría causar carcinoma de células escamosas. Todos los estudios disponibles muestran que el riesgo de cáncer de piel es mayor, cuando la exposición a la radiación se produce a edades más tempranas que en más avanzadas; las pruebas indican que el exceso de riesgo para este tipo de cáncer, tiene una duración de varios años después de la irradiación. Por lo tanto, los pacientes previamente tratados con radiaciones ionizantes requieren un seguimiento permanente, para identificar el carcinoma cutáneo en una etapa temprana.


Several epidemiologic studies of ionizing radiation and skin cancer have shown that radiation causes non melanoma skin cancer, mainly basal cell carcinoma. Little is known about the dose of ionizing radiation that could cause squamous cell carcinoma. All available studies show that skin cancer risk is greater from radiation exposure at young ages than at older ages and the evidence indicates that the excess risk of skin cancer lasts for several years following irradiation. Therefore patients previously treated with ionizing radiation require lifelong monitoring to identify skin cancer at an early stage.

2.
Rev. argent. dermatol ; 95(4): 30-35, dic. 2014. ilus
Artículo en Español | BINACIS | ID: bin-131286

RESUMEN

Varios estudios epidemiológicos de la radiación ionizante y el cáncer de piel, han demostrado que la radiación causa cáncer de piel no melanoma, principalmente carcinoma basocelular. Poco se sabe sobre la dosis de radiación ionizante, que podría causar carcinoma de células escamosas. Todos los estudios disponibles muestran que el riesgo de cáncer de piel es mayor, cuando la exposición a la radiación se produce a edades más tempranas que en más avanzadas; las pruebas indican que el exceso de riesgo para este tipo de cáncer, tiene una duración de varios años después de la irradiación. Por lo tanto, los pacientes previamente tratados con radiaciones ionizantes requieren un seguimiento permanente, para identificar el carcinoma cutáneo en una etapa temprana.(AU)


Several epidemiologic studies of ionizing radiation and skin cancer have shown that radiation causes non melanoma skin cancer, mainly basal cell carcinoma. Little is known about the dose of ionizing radiation that could cause squamous cell carcinoma. All available studies show that skin cancer risk is greater from radiation exposure at young ages than at older ages and the evidence indicates that the excess risk of skin cancer lasts for several years following irradiation. Therefore patients previously treated with ionizing radiation require lifelong monitoring to identify skin cancer at an early stage.(AU)

3.
Acta Physiol (Oxf) ; 204(4): 502-12, 2012 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-21933354

RESUMEN

AIMS: To identify the causes for the inhomogeneity of ventricular repolarization and increased QT dispersion in hypothyroid mice. METHODS: We studied the effects of 5-propyl-2-thiouracil-induced hypothyroidism on the ECG, action potential (AP) and current density of the repolarizing potassium currents I(to,fast), I(to,slow), I(K,slow) and I(ss) in enzymatically isolated myocytes from three different regions of mouse heart: right ventricle (RV), epicardium of the left ventricle (Epi-LV) and interventricular septum. K(+) currents were recorded with the patch-clamp technique. Membranes from isolated ventricular myocytes were extracted by centrifugation. Kv4.2, Kv4.3, KChIP and Na/Ca exchanger proteins were visualized by Western blot. RESULTS: The frequency or conduction velocity was not changed by hypothyroidism, but QTc was prolonged. Neither resting membrane potential nor AP amplitude was modified. The action potential duration (APD)(90) increased in the RV and Epi-LV, but not in the septum. Hypothyroid status has no effect either on I(to,slow), I(k,slow) or I(ss) in any of the regions analysed. However, I(to,fast) was significantly reduced in the Epi-LV and in the RV, whereas it was not altered in cells from the septum. Western blot analysis reveals a reduction in Kv4.2 and Kv4.3 protein levels in both the Epi-LV and the RV and an increase in Na/Ca exchanger. CONCLUSION: From these results we suggest that the regional differences in APD lengthening, and thus in repolarization inhomogeneity, induced by experimental hypothyroidism are at least partially explained by the uneven decrease in I(to,fast) and the differences in the relative contribution of the depolarization-activated outward currents to the repolarization process.


Asunto(s)
Potenciales de Acción/fisiología , Ventrículos Cardíacos/fisiopatología , Hipotiroidismo/fisiopatología , Células Musculares/metabolismo , Animales , Western Blotting , Modelos Animales de Enfermedad , Electrocardiografía , Masculino , Ratones , Ratones Endogámicos BALB C , Técnicas de Placa-Clamp , Canales de Potasio con Entrada de Voltaje/metabolismo
4.
Enferm Intensiva ; 21(1): 11-9, 2010.
Artículo en Español | MEDLINE | ID: mdl-20170831

RESUMEN

INTRODUCTION: Within the context of participatory action research (PAR), a 4-stage process was established with the general aim of promoting improvements in the care offered to families of patients in the Intensive Care Unit (ICU). The 4 stages consisted of a situational diagnosis, proposals for change, the design and implementation of the proposals, and an evaluation. This paper presents the first 2 stages. OBJECTIVES: To define the attention given to families of patients in the Intensive Care Unit. To reach a consensus on areas for action/intervention in the unit. MATERIALS AND METHOD: A qualitative methodology. DESIGN: PAR. Data-collection technique: 4 focus groups made up of 10 professionals, and consensus with support groups made up of 30 members. Content analysis was performed. The theoretical saturation point was reached. RESULTS: Two documents were drawn up: 1) A situational diagnosis, describing the current situation of the attention given to families and 2) 10 proposals for change, 5 of which were given priority. They were: a session to familiarize professionals with evidence concerning families of patients in the ICU and the handing out of informative leaflets, the improvement of (nurse-family and intra-team) informative procedures, more privacy for patients and a reduction in environmental noise, a training plan for professionals, and change in the visiting policy. CONCLUSION: By using consensus-based methodologies, strategies for change can be prioritized and designed, adapted to the context in which they will be applied.


Asunto(s)
Enfermedad Crítica , Familia , Adulto , Consenso , Familia/psicología , Humanos , Unidades de Cuidados Intensivos , Modelos Teóricos
5.
Epidemiol Infect ; 136(6): 823-32, 2008 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-17662166

RESUMEN

An outbreak of Legionnaire's disease was detected in Pamplona, Spain, on 1 June 2006. Patients with pneumonia were tested to detect Legionella pneumophila antigen in urine (Binax Now; Binax Inc., Scarborough, ME, USA), and all 146 confirmed cases were interviewed. The outbreak was related to district 2 (22 012 inhabitants), where 45% of the cases lived and 50% had visited; 5% lived in neighbouring districts. The highest incidence was found in the resident population of district 2 (3/1000 inhabitants), section 2 (14/1000). All 31 cooling towers of district 2 were analysed. L. pneumophila antigen (Binax Now) was detected in four towers, which were closed on 2 June. Only the strain isolated in a tower situated in section 2 of district 2 matched all five clinical isolates, as assessed by mAb and two genotyping methods, AFLP and PFGE. Eight days after closing the towers, new cases ceased appearing. Early detection and rapid coordinated medical and environmental actions permitted immediate control of the outbreak and probably contributed to the null case fatality.


Asunto(s)
Brotes de Enfermedades , Legionella pneumophila/aislamiento & purificación , Enfermedad de los Legionarios/epidemiología , Adulto , Anciano , Anciano de 80 o más Años , Análisis del Polimorfismo de Longitud de Fragmentos Amplificados , Animales , Antígenos Bacterianos/análisis , Técnicas de Tipificación Bacteriana , Control de Enfermedades Transmisibles , Demografía , Electroforesis en Gel de Campo Pulsado , Femenino , Genotipo , Humanos , Incidencia , Legionella pneumophila/clasificación , Enfermedad de los Legionarios/microbiología , Masculino , Persona de Mediana Edad , España/epidemiología , Orina/microbiología , Microbiología del Agua
6.
Epilepsia ; 42(10): 1363-5, 2001 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-11737174

RESUMEN

PURPOSE: Topiramate (TPM) is an antiepileptic agent, first licensed in the United Kingdom in 1994, that is used in the treatment of patients with refractory seizure disorders. TPM is a monosaccharide d-fructose derivate, with sulfamate function, and so far, few adverse side effects have been reported. METHODS: We describe three patients with epilepsy who were treated with TPM and developed hypohidrosis, heat and exercise intolerance, as well as fever. The sudomotor function was assessed after peripheral stimulation with pilocarpine iontophoresis. RESULTS: Sweat response was reduced in all three patients. Signs and symptoms ceased after drug suppression. CONCLUSIONS: This side effect associated with TPM, which has not been described previously, can be clinically significant during heat stress and exercise challenge.


Asunto(s)
Anticonvulsivantes/efectos adversos , Epilepsia/tratamiento farmacológico , Fructosa/análogos & derivados , Fructosa/efectos adversos , Hipohidrosis/inducido químicamente , Adolescente , Anticonvulsivantes/uso terapéutico , Niño , Epilepsias Parciales/tratamiento farmacológico , Fiebre/inducido químicamente , Fructosa/uso terapéutico , Humanos , Hipohidrosis/diagnóstico , Lactante , Masculino , Espasmos Infantiles/tratamiento farmacológico , Sudoración/efectos de los fármacos , Topiramato
7.
Rev Esp Enferm Dig ; 93(7): 423-32, 2001 Jul.
Artículo en Inglés, Español | MEDLINE | ID: mdl-11685939

RESUMEN

OBJECTIVE: To evaluate the characteristics of flutamide induced hepatotoxicity. MATERIAL AND METHODS: In this retrospective study we have analyzed all cases of flutamide hepatotoxicity submitted to the Andalucian Registry of drug-induced liver disease. Data were collected using a structured reporting form. Causality assessment was performed using two clinical scales: the standard CIOMS scale and the recently developed María and Victorino scale. RESULTS: Nine of 185 patients (4.9%) were identified. In 8 male patients, mean age 75 years (range 65-83), flutamide was indicated for palliative therapy of disseminated prostatic carcinoma, and in one young female (14 years) was given for the treatment of facial hirsutism. The mean duration of the flutamide therapy was 151 days (range 4-443). All patients presented with overt liver injury, the most frequent features being asthenia, anorexia, weight loss, nausea, vomiting and jaundice. No patient showed hypersensitivity features. In two patients (22%) the hepatic damage evolved to fulminant liver failure, one of them undergoing a liver transplantation and the other subsequently died. An additional patient died of a non-hepatic related cause when his liver function was improving. Causality assessment by the two clinical scales did not exclude any case, but the two patients who died where classified as unlikely by the María and Victorino scale. CONCLUSIONS: Flutamide can induce severe acute hepatitis, probably due to an idiosyncratic metabolic mechanism. Liver tests monitoring should probably be mandatory during the first months of flutamide therapy and the drug withdrawn if transaminases began to increase.


Asunto(s)
Antineoplásicos Hormonales/efectos adversos , Enfermedad Hepática Inducida por Sustancias y Drogas , Flutamida/efectos adversos , Hígado/efectos de los fármacos , Adolescente , Anciano , Anciano de 80 o más Años , Femenino , Hirsutismo/tratamiento farmacológico , Humanos , Masculino , Neoplasias de la Próstata/tratamiento farmacológico , Estudios Retrospectivos
8.
Br J Pharmacol ; 134(6): 1195-206, 2001 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-11704639

RESUMEN

1. Two sodium channel toxins, BgII and BgIII, have been isolated and purified from the sea anemone Bunodosoma granulifera. Combining different techniques, we have investigated the electrophysiological properties of these toxins. 2. We examined the effect of BgII and BgIII on rat ventricular strips. These toxins prolong action potentials with EC50 values of 60 and 660 nM and modify the resting potentials. 3. The effect on Na+ currents in rat cardiomyocytes was studied using the patch-clamp technique. BgII and BgIII slow the rapid inactivation process and increase the current density with EC50 values of 58 and 78 nM, respectively. 4. On the cloned hH1 cardiac Na+ channel expressed in Xenopus laevis oocytes, BgII and BgIII slow the inactivation process of Na+ currents (respective EC50 values of 0.38 and 7.8 microM), shift the steady-state activation and inactivation parameters to more positive potentials and the reversal potential to more negative potentials. 5. The amino acid sequences of these toxins are almost identical except for an asparagine at position 16 in BgII which is replaced by an aspartic acid in BgIII. In all experiments, BgII was more potent than BgIII suggesting that this conservative residue is important for the toxicity of sea anemone toxins. 6. We conclude that BgII and BgIII, generally known as neurotoxins, are also cardiotoxic and combine the classical effects of sea anemone Na+ channels toxins (slowing of inactivation kinetics, shift of steady-state activation and inactivation parameters) with a striking decrease on the ionic selectivity of Na+ channels.


Asunto(s)
Potenciales de Acción/efectos de los fármacos , Venenos de Cnidarios/farmacología , Corazón/efectos de los fármacos , Anémonas de Mar/química , Canales de Sodio/efectos de los fármacos , Secuencia de Aminoácidos , Animales , Clonación Molecular , Venenos de Cnidarios/aislamiento & purificación , Relación Dosis-Respuesta a Droga , Ventrículos Cardíacos/citología , Ventrículos Cardíacos/efectos de los fármacos , Técnicas In Vitro , Modelos Biológicos , Datos de Secuencia Molecular , Técnicas de Placa-Clamp , Ratas , Análisis de Secuencia de Proteína , Homología de Secuencia de Aminoácido , Función Ventricular , Xenopus laevis
9.
J Trauma ; 51(2): 253-9; discussion 259-60, 2001 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-11493781

RESUMEN

BACKGROUND: This study investigated the effects of intra-abdominal blood on the systemic response to peritonitis using a murine model of hemorrhage, peritonitis, and multiple organ dysfunction syndrome. METHODS: The model used male ICR mice subjected to hemorrhage and intraperitoneal zymosan. Half of the mice received intraperitoneal blood. Outcome measures included lung myeloperoxidase, lung edema, lung injury score, and plasma and lung tissue chemokine production. RESULTS: Peritoneal blood (in association with peritoneal inflammation) increased lung neutrophil sequestration (myeloperoxidase) (2.56 +/- 1.42 vs. 1.45 +/- 0.49 U/left lung, p = 0.04) and lung weight (0.11 +/- 0.04 vs. 0.07 +/- 0.02 g/left lung, p = 0.02), and was associated with significantly higher chemokine levels in plasma (KC and MCP-1) and lung tissue (KC, MIP-2, and MCP-1). Both plasma and lung tissue neutrophil chemoattractants KC and MIP-2 were significantly linearly correlated with myeloperoxidase (p < 0.009), and lung tissue KC (a neutrophil chemokine) and MCP-1 and MIP-1alpha (mononuclear cell chemokines) correlated with lung injury score (p < 0.003). CONCLUSION: Although blood alone in the peritoneal cavity was well tolerated, in conjunction with inflammation, it was synergistic in amplifying the systemic inflammatory response. The amplified lung injury in this model was associated with significant increases in circulating and lung tissue chemokine concentrations.


Asunto(s)
Quimiocinas/sangre , Citocinas/sangre , Hemoperitoneo/inmunología , Peritonitis/inmunología , Síndrome de Respuesta Inflamatoria Sistémica/inmunología , Animales , Recuento de Leucocitos , Pulmón/inmunología , Masculino , Ratones , Ratones Endogámicos ICR , Insuficiencia Multiorgánica/inmunología , Neutrófilos/inmunología
10.
Fundam Clin Pharmacol ; 15(1): 9-17, 2001 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-11468008

RESUMEN

In long term treatment, thiazide diuretics such as hydrochlorothiazide (HCTZ) lower blood pressure by decreasing peripheral resistance rather than by their diuretic effect. This action has been attributed to the opening of Ca2+-activated K+ channels in vascular smooth muscle cells. However, little is known about their cardiac cellular actions. Here we investigated the possible actions of HCTZ on action potential and contraction of rat ventricular muscle strips and on the ionic currents of isolated rat ventricular cardiomyocytes. HCTZ depressed ventricular contraction with an IC30 of 1.85 microM (60% decrease at 100 microM). Action potential duration at -60 mV and maximal rate of depolarization were, however, only slightly decreased by 12% and 22%, respectively, at 100 microM. At the single cell level, HCTZ (100 microM) depressed the fast Na+ current (INa) and the L-type Ca2+ current (ICaL) by 30% and 20%, respectively. The effects on ICaL were not voltage-or frequency-dependent. In cells intracellularly perfused with 50 microM cyclic adenosine, monophosphate HCTZ reduced ICaL by 33%. The transient (Ito), the delayed rectifier and the inward rectifier potassium currents were decreased by 20% at 100 microM HCTZ. The effects on Ito were voltage-dependent. In conclusion, HCTZ at high concentrations possesses a negative inotropic action that could be in part due to its blocking action on INa and ICaL. The actions of HCTZ on multiple cardiac ionic currents could explain its weak effect on action potential duration.


Asunto(s)
Corazón/efectos de los fármacos , Hidroclorotiazida/farmacología , Inhibidores de los Simportadores del Cloruro de Sodio/farmacología , Potenciales de Acción/efectos de los fármacos , Animales , Calcio/metabolismo , Diuréticos , Relación Dosis-Respuesta a Droga , Electrofisiología , Corazón/fisiología , Sistema de Conducción Cardíaco/efectos de los fármacos , Sistema de Conducción Cardíaco/fisiología , Ventrículos Cardíacos/efectos de los fármacos , Técnicas In Vitro , Potenciales de la Membrana/efectos de los fármacos , Músculo Liso/citología , Músculo Liso/efectos de los fármacos , Contracción Miocárdica/efectos de los fármacos , Miocardio/citología , Técnicas de Placa-Clamp , Canales de Potasio/efectos de los fármacos , Ratas , Sodio/metabolismo , Estimulación Química
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA